发明名称 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND -1-OXOISOINDOLINES AND METHOD OF REDUCING TNF.ALPHA. LEVELS
摘要 <p>Provided are substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF.alpha. in a mammal, for example of the following formula: (see above formula) in which: one of X and Y is C=O and the other of X and Y is C=O or CH2; (i) each of R1, R2, R3, and R4, independently of the others, is halo, alkyl of 1 to 4 carbon atoms, or alkoxy of 1 to 4 carbon atoms or (ii) one of R1, R2, R3, and R4 is -NHR5 and the remaining of R1, R2, R3, and R4 are hydrogen; R5 is hydrogen, alkyl of 1 to 8 carbon atoms, or CO-R7-CH(R10)NR8R9; R6 is hydrogen, alkyl of 1 to 8 carbon atoms, benzyl, chloro, or fluoro; R7 is m-phenylene or p-phenylene or -(C n H2n)- in which n has a value of 0 to 4; each of R8 and R9 taken independently of the other is hydrogen or alkyl of 1 to 8 carbon atoms, or R8 and R9 taken together are tetramethylene, pentamethylene, hexamethylene, or -CH2CH2XCH2CH2- in which X is -O-, -S- or -NH-; R10 is hydrogen, alkyl of 1 to 8 carbon atoms, or phenyl; and (b) the acid addition salts of said compounds which contain a nitrogen atom capable of being protonated. A typical embodiment is 1-oxo-2-(2,6-dioxo-3- methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline.</p>
申请公布号 CA2291218(C) 申请公布日期 2009.10.13
申请号 CA19982291218 申请日期 1998.05.28
申请人 CELGENE CORPORATION 发明人 CHEN, ROGER SHEN-CHU;STIRLING, DAVID I.;MULLER, GEORGE W.
分类号 C07D401/04;A61K31/445;A61K31/454;A61P1/04;A61P9/02;A61P9/04;A61P9/10;A61P17/06;A61P19/02;A61P29/00;A61P31/06;A61P33/06;A61P35/00;A61P37/06;A61P43/00 主分类号 C07D401/04
代理机构 代理人
主权项
地址